knowledge -WSS

knowledge

author：comprehensive 2025-09-03 14:42:10 - browse：13591

On Tuesday, Google DeepMind and Isomorphic Labs announced a significant progress update on the next iteration of AlphaFold, the deep learning model that in 2020 cracked the problem of predicting a protein’s structure from its amino acid sequence, leapfrogging other approaches in computational biology.

Now, the companies say they have developed the model to predict not just standalone protein structures, but what proteins look like in combination with several classes of molecules, including small molecules and nucleic acids — capabilities that are key for drug development.

“We really needed to make progress on protein-ligand binding and co-folding of ligands with proteins in order to help us design more effective drugs,” said Demis Hassabis, CEO of both DeepMind and Isomorphic Labs, which spun out in 2021 with the goal of applying deep learning approaches to drug discovery. The updated model can also predict protein structures after they’ve been modified. “Basically the new AlphaFold can cope with all of these different things, which is pretty amazing.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： First Opinion Podcast: Long Covid needs a new approach

WSS

FDA gives detailed accounting of AI

FDA warns J&J's Abiomed: We will regulate your software

The EU Joint Clinical Assessment needs to live up to its promise

2023 STAT Wunderkinds: get to know the winners

Roche to buy Carmot Therapeutics, developer of obesity drugs

Studies point to risks of excluding people with obesity from drug trials

leisure time

knowledge

knowledge

DIEP, the 'gold standard' of breast reconstruction, is under threat

Impact of Dobbs ruling felt at reproductive medicine meeting

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Researchers explore possible ties between long Covid, menopause

Medicare proposal to cover medical devices draws a mixed reaction

In diabetes hearing, Sanders takes on a new foe: food makers

In Memoriam: Notable people who died in 2023

Patients' immediate access to test results puts radiologists in a bind

Novavax promises a turnaround & Lilly roils the obesity market

Americans' trust in science, scientist continues decline: Report

hotspot

FDA approves world's first CRISPR

Pregnancy discrimination could be enabled by AI

Researchers explore possible ties between long Covid, menopause

First Opinion Podcast: Long Covid needs a new approach

Pfizer plans to depart BIO

Despite FDA approval for Lyfgenia, Bluebird faces stiff competition

knowledge

knowledge

hotspot

hotspot